Zoladex 3.6 MG implant syrns
Ended Awarded Last action
- Contract number
- SPE2DR26F9KZ0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,156
Award facts
- Contract value 100% obligated
- $2,155.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $2,155.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zoladex 3.6 mg implant syringes, with an ultimate completion date of February 4, 2026. This competitively awarded contract carries no set-aside designation and represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.999 billion through December 2031. The performance location is in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered.
Zoladex is a hormone therapy product primarily used in oncology and endocrinology treatment regimens. This delivery order reflects routine pharmaceutical procurement through the DLA's medical supply chain, which serves military treatment facilities, veterans' healthcare programs, and other federal medical institutions. AmerisourceBergen's extensive federal contract portfolio demonstrates the company's established capability to meet government requirements across diverse therapeutic domains, from specialty medications to vaccines and medical devices, positioning it as a critical vendor for federal healthcare delivery.
Quick answers
Who was awarded contract SPE2DR26F9KZ0?
SPE2DR26F9KZ0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F9KZ0 worth?
The government has obligated $2,156 on SPE2DR26F9KZ0.
Is contract SPE2DR26F9KZ0 an order under another contract?
Yes. SPE2DR26F9KZ0 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9KZ0 competed?
The extent of competition for SPE2DR26F9KZ0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award